These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2141825)

  • 1. Pathologic changes in the long-term transplanted heart: a morphometric study of myocardial hypertrophy, vascularity, and fibrosis.
    Rowan RA; Billingham ME
    Hum Pathol; 1990 Jul; 21(7):767-72. PubMed ID: 2141825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained myocardial hypertrophy seven years or more after heart transplantation: a morphometric study of endomyocardial specimens.
    Rowan RA; Billingham ME
    J Heart Lung Transplant; 1992; 11(2 Pt 1):350-2. PubMed ID: 1533535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocyte hypertrophy in the transplanted heart. A morphometric analysis.
    Imakita M; Tazelaar HD; Rowan RA; Masek MA; Billingham ME
    Transplantation; 1987 Jun; 43(6):839-42. PubMed ID: 2954283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrosis in the transplanted heart and its relation to donor ischemic time. Assessment with polarized light microscopy and digital image analysis.
    Pickering JG; Boughner DR
    Circulation; 1990 Mar; 81(3):949-58. PubMed ID: 2306841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocyte cellular hypertrophy is responsible for ventricular remodelling in the hypertrophied heart of middle aged individuals in the absence of cardiac failure.
    Olivetti G; Melissari M; Balbi T; Quaini F; Cigola E; Sonnenblick EH; Anversa P
    Cardiovasc Res; 1994 Aug; 28(8):1199-208. PubMed ID: 7954623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis of end-stage failure in ischemic cardiomyopathy in humans.
    Beltrami CA; Finato N; Rocco M; Feruglio GA; Puricelli C; Cigola E; Quaini F; Sonnenblick EH; Olivetti G; Anversa P
    Circulation; 1994 Jan; 89(1):151-63. PubMed ID: 8281642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction.
    Mohammed SF; Hussain S; Mirzoyev SA; Edwards WD; Maleszewski JJ; Redfield MM
    Circulation; 2015 Feb; 131(6):550-9. PubMed ID: 25552356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporine induced myocardial fibrosis: a unique controlled case report.
    Karch SB; Billingham ME
    J Heart Transplant; 1985 Feb; 4(2):210-2. PubMed ID: 3916487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphology of the heart in hypertrophy.
    Ferrans VJ
    Hosp Pract (Off Ed); 1983 Jul; 18(7):67-78. PubMed ID: 6222961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation between coronary stenosis and myocardial lesions determined by a semiquantitative approach to myocardial fibrosis and hypertrophy due to ischemia.
    Okada R; Kawai S; Ishijima M
    Am J Cardiol; 1989 Mar; 63(10):2E-6E. PubMed ID: 2522268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of endomyocardial biopsy in the diagnosis of chronic rejection in human heart transplantation.
    Pardo Mindán FJ; Panizo A; Lozano MD; Herreros J; Mejía S
    Clin Transplant; 1997 Oct; 11(5 Pt 1):426-31. PubMed ID: 9361935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Histological and ultrastructural characteristics of the recipients' myocardium 7-14 years after orthotopic transplantation of the heart (according to endomyocardial biopsy)].
    Dzemeshkevich SL; Tsyplenkova VG; Samko AN; Kukharchuk VV; Skridlevskaia EA
    Arkh Patol; 2004; 66(3):31-3. PubMed ID: 15318554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Morphologic findings during regression of heart hypertrophy].
    Frenzel H
    Z Kardiol; 1985; 74 Suppl 7():107-18. PubMed ID: 2936013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early ultrastructural changes in the myocardium following thyroxine-induced hypertrophy.
    Craft-Cormney C; Hansen JT
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1980; 33(3):267-73. PubMed ID: 6110274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of ACE inhibition versus non-ACE inhibitor antihypertensive treatment on myocardial fibrosis in patients with arterial hypertension. Retrospective analysis of 120 patients with left ventricular endomyocardial biopsies.
    Brilla CG; Rupp H; Maisch B
    Herz; 2003 Dec; 28(8):744-53. PubMed ID: 14689110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of captopril on the prevention and regression of myocardial cell hypertrophy and interstitial fibrosis in pressure overload cardiac hypertrophy.
    Rossi MA; Peres LC
    Am Heart J; 1992 Sep; 124(3):700-9. PubMed ID: 1387507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transplantation-induced atrophy of normal and hypertrophic rat hearts: effect on cardiac myocytes and capillaries.
    Rakusan K; Heron MI; Kolar F; Korecky B
    J Mol Cell Cardiol; 1997 Mar; 29(3):1045-54. PubMed ID: 9152865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of acute or chronic rejection on myocardial collagen density in serial endomyocardial biopsy specimens from cardiac allografts.
    Fornes P; Heudes D; Simon D; Guillemain R; Amrein C; Bruneval P
    J Heart Lung Transplant; 1996 Aug; 15(8):796-803. PubMed ID: 8878762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of myocardial changes between pressure induced hypertrophy and normal growth in the rat heart.
    van der Laarse A; Vliegen HW; van der Nat KH; Hollaar L; Egas JM; Swier GP; van den Broek AJ
    Cardiovasc Res; 1989 Apr; 23(4):308-14. PubMed ID: 2531632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What the dead can teach the living: systemic nature of heart failure with preserved ejection fraction.
    Kitzman DW; Upadhya B; Vasu S
    Circulation; 2015 Feb; 131(6):522-4. PubMed ID: 25552355
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.